Guggenheim Downgrades Revance Therapeutic (RVNC) to Neutral

August 12, 2024 10:40 AM

Guggenheim analyst Seamus Fernandez downgraded Revance Therapeutic (NASDAQ: RVNC) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found